by acaballero | Mar 25, 2024 | Industry insights
Written by Kiera Lander, Assistant Project Manager The National Institute for Health and Care Excellence (NICE) has long been at the forefront of health technology assessment (HTA), ensuring that patients have access to innovative, efficacious medicines....
by acaballero | Mar 18, 2024 | Industry insights
Written by Brian O’Toole, HTA Writing Lead Last year I changed jobs. It was a major life decision that took time to make as it meant leaving the comfort and familiarity of academia for the hustle and bustle of a market access consultancy. For the past...
by acaballero | Mar 13, 2024 | Industry insights
Written by Mark Pennington, Consultant Health Economist With the UK’s National Health Service (NHS) facing an unprecedented patient demand for healthcare, there is increasing interest in artificial intelligence (AI) and how it can support healthcare diagnoses....
by acaballero | Feb 1, 2023 | Industry insights
Written by Oliver Burn, Consultant Health Economist, and Margaret Petrou, Consultant Health Economist Adapting a global economic model for Health Technology Assessment (HTA) submissions in several countries can be challenging, as requirements can vary considerably...
by acaballero | Nov 8, 2022 | Industry insights
Written by Mark Pennington, Consultant Health Economist A National Institute for Health and Care Excellence (NICE) recommendation can open the door to widespread adoption for a new medical device. But does getting a NICE recommendation require extensive evidence on...
by Rachel Montague | Jul 25, 2022 | Industry insights
Written by Beth Hancock, Senior Consultant Health Economist Pharmaceutical companies often develop global cost-effectiveness and budget impact models, with the aim of adapting them for specific countries. In principle, this is an efficient and streamlined process, but...
